Home
>
National Drug Code (NDC)
>
Topiramate
Topiramate - 50436-9951-2 - (Topiramate)
Drug Information of Topiramate
| Product NDC: | 50436-9951 |
| Proprietary Name: | Topiramate |
| Non Proprietary Name: | Topiramate |
| Active Ingredient(s): | 100 mg/1 & nbsp; Topiramate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Topiramate
| Product NDC: | 50436-9951 |
| Labeler Name: | Unit Dose Services |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA079162 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110101 |
Package Information of Topiramate
| Package NDC: | 50436-9951-2 |
| Package Description: | 30 TABLET in 1 BOTTLE (50436-9951-2) |
NDC Information of Topiramate
| NDC Code | 50436-9951-2 |
| Proprietary Name | Topiramate |
| Package Description | 30 TABLET in 1 BOTTLE (50436-9951-2) |
| Product NDC | 50436-9951 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Topiramate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110101 |
| Marketing Category Name | ANDA |
| Labeler Name | Unit Dose Services |
| Substance Name | TOPIRAMATE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
